Financial Advocates Investment Management Novavax Inc Transaction History

Financial Advocates Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $110,472 - $229,258	3,045 Added 30.18%	13,133 $676,000
Q1 2022 May 11, 2022	SELL	$69.73 - $142.9 $3.34 Million - $6.85 Million	-47,935 Reduced 82.61%	10,088 $743,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $3.56 Million - $5.76 Million	26,432 Added 83.67%	58,023 $3.53 Million
Q3 2021 Nov 04, 2021	BUY	$177.8 - $270.58 $4.59 Million - $6.99 Million	25,816 Added 447.03%	31,591 $5.08 Million
Q2 2021 Aug 03, 2021	BUY	$121.0 - $257.67 $542,322 - $1.15 Million	4,482 Added 346.64%	5,775 $1.62 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $101,810 - $180,373	1,293 New	1,293 $726,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.